Skip to main content
Premium Trial:

Request an Annual Quote

City of Hope: David Craig

David Craig has been appointed as founding chair of the Department of Integrative Translational Sciences in the Beckman Research Institute of City of Hope, effective June 30. He will also be deputy director of translational sciences at the Beckman Research Institute and associate director of data science for City of Hope's comprehensive cancer center. Craig joins City of Hope from the University of Southern California, where he was codirector of the Institute of Translational Genomics and vice chair of the Department of Translational Genomics at the Keck School of Medicine. He was also director of Norris Comprehensive Cancer Center Molecular Genomics Core. Prior to that, he was deputy director of bioinformatics at the Translational Genomics Research Institute (TGen), which is part of City of Hope; director of TGen's neurogenomics division; and cofounder of a genomics laboratory. He holds a PhD from the University of Washington, where he focused on bioengineering.

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.